|
|
|
|
|
Home >> Investor Relations >> Corporate Governance >> Insider Transactions
Insider Transactions
Date  |
Name |
Title |
Type |
Shares Traded |
Price Range |
| Feb 7, 2008 |
topper james n |
Director |
Buy |
25,400 |
9.96 - 10.20 |
| Feb 6, 2008 |
fhm iv lp |
Beneficial Owner (10% or more) |
Buy |
45,477 |
10.00 - 10.25 |
| Feb 6, 2008 |
topper james n |
Director |
Buy |
45,477 |
10.00 - 10.25 |
| Feb 5, 2008 |
fhm iv lp |
Beneficial Owner (10% or more) |
Buy |
35,536 |
10.16 - 10.31 |
| Feb 5, 2008 |
fhm iv lp |
Beneficial Owner (10% or more) |
Buy |
32,864 |
10.32 - 10.50 |
| Feb 5, 2008 |
topper james n |
Director |
Buy |
35,536 |
10.16 - 10.31 |
| Feb 5, 2008 |
topper james n |
Director |
Buy |
32,864 |
10.32 - 10.50 |
| Feb 4, 2008 |
fhm iv lp |
Beneficial Owner (10% or more) |
Buy |
25,352 |
9.92 - 10.31 |
| Feb 4, 2008 |
fhm iv lp |
Beneficial Owner (10% or more) |
Buy |
33,823 |
10.32 - 10.50 |
| Feb 4, 2008 |
topper james n |
Director |
Buy |
25,352 |
9.92 - 10.31 |
| Feb 4, 2008 |
topper james n |
Director |
Buy |
33,823 |
10.32 - 10.50 |
| Feb 1, 2008 |
crowley john f |
Officer |
Automatic Sell |
10,000 |
10.00 |
| Feb 1, 2008 |
dentzer james e |
Officer |
Disposition (Non Open Market) |
220 |
10.24 |
| Feb 1, 2008 |
fhm iv lp |
Beneficial Owner (10% or more) |
Buy |
5,600 |
9.01 - 9.08 |
| Feb 1, 2008 |
fhm iv lp |
Beneficial Owner (10% or more) |
Buy |
32,100 |
9.09 - 9.44 |
| Feb 1, 2008 |
fhm iv lp |
Beneficial Owner (10% or more) |
Buy |
28,700 |
9.45 - 9.74 |
| Feb 1, 2008 |
fhm iv lp |
Beneficial Owner (10% or more) |
Buy |
13,600 |
9.75 - 9.93 |
| Feb 1, 2008 |
licholai gregory p |
Officer |
Sell |
10,000 |
9.90 |
| Feb 1, 2008 |
palling david |
Officer |
Sell |
3,000 |
10.00 |
| Feb 1, 2008 |
topper james n |
Director |
Buy |
5,600 |
9.01 - 9.08 |
|
|
Stock transaction information provided by EDGAR Online. Amicus Therapeutics, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.
|
|
|
|
|
|
|
